The known indications of ozone macroautologous blood treatment almost cover a wide range of diseases from cardiovascular, cerebrovascular and peripheral vascular diseases, to renal diseases, digestive diseases, blood diseases, endocrine diseases, geriatrics, infectious diseases,, venereal diseases, dermatological diseases, burns, tumors, surgery, pain, orthopedics and so on. And in the treatment of cardiovascular and cerebrovascular diseases and the treatment of chronic pain has a very significant therapeutic effect, and to avoid the adverse effects of drugs, long-term efficacy is much higher than the effect of drug therapy.
The State Food and Drug Administration on the medical ozone therapy instrument medical device classification is defined as follows:
State Food and Drug Administration Mech [2006] 454: medical ozone therapy instrument, medical ozone cardiovascular disease, liver disease therapeutic instrument: ozone, clean and sterile and contain a certain concentration of ozone gas into the infusion bottle, blood bag, or the autologous back to the blood after treatment. It is used to improve the blood rheology index, and to treat the blood of autologous blood transfusion. It is used to improve blood rheology index, improve microcirculation, anti-inflammation, and promote tissue repair. Treatment of thrombosis, post-stroke rehabilitation, coronary atherosclerosis, hyperlipidemia, chronic viral hepatitis. Managed as a Class III medical device.
The large self-blood ozone therapeutic instrument is developed on the basis of pain ozone therapeutic instrument specializing in the treatment of cardiovascular and cerebrovascular diseases of a medical device.